Aclarion, Inc. Common Stock
Symbol: ACON (NASDAQ)
7.08
▼ (-0.35%) -0.025
Company Description:
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Key Stats
- Today's Open: $7.137
- Today's High: $7.25
- Today's Low: $7.011
- Today's Volume: 3.30K
- Yesterday Close: $7.1
- Yesterday High: $7.1
- Yesterday Low: $7
- Yesterday Volume: 6.94K
- Last Min Volume: 25
- Last Min High: $7.075
- Last Min Low: $7.075
- Last Min VWAP: $7.075
Company Profile
- Name: Aclarion, Inc. Common Stock
- Website: https://www.aclarion.com
- Listed Date: 2022-04-22
- Location: BROOMFIELD, CO
- Market Status: Active
- CIK Number: 0001635077
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $4.13M
- Round Lot: 100
- Outstanding Shares: 582.37K
- Asset Type: CS
RECENT FILINGS FOR ACON
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-09-03 | 3 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-21 | 8-K | View |
| 2025-07-07 | DEFA14A | View |
| 2025-07-07 | 8-K | View |
| 2025-06-20 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-13 | DEF 14A | View |
| 2025-05-05 | EFFECT | View |
| 2025-05-02 | PRE 14A | View |
| 2025-04-30 | CORRESP | View |
| 2025-04-29 | UPLOAD | View |
| 2025-04-25 | S-3 | View |
| 2025-04-23 | 8-K | View |
| 2025-04-09 | 10-K | View |
| 2025-03-31 | NT 10-K | View |
| 2025-03-28 | 8-K | View |
| 2025-03-13 | 8-K | View |
Latest News on ACON